Contemporary Issues in Lung CancerJones & Bartlett Publishers, 2009 M02 12 - 364 pages In the United States, lung cancer is the second most commonly diagnosed cancer and the leading cause of cancer death. Even more devastating is its five-year survival rate of only 15.8%. Despite these dismal facts, lung cancer receives little national attention and research and funding for lung cancer lags behind other cancers. The intent of Contemporary Issues in Lung Cancer: A Nursing Perspective Second Edition is to provide oncology nurses and healthcare professionals with in-depth information on the issues that surround this disease, so that they might impact both education and research and provide better care for their patients. |
From inside the book
Results 1-5 of 89
Page vi
... Risk: Indoor Radon Exposure 217 Tina M. St. John Part Four Psychosocial Issues of Individuals with Lung Cancer . .231 12 Living with Hope: Lung Cancer 233 Katherine Katen Moore 13 Meaning of Illness in Cancer 245 Pamela M. Calarese Part ...
... Risk: Indoor Radon Exposure 217 Tina M. St. John Part Four Psychosocial Issues of Individuals with Lung Cancer . .231 12 Living with Hope: Lung Cancer 233 Katherine Katen Moore 13 Meaning of Illness in Cancer 245 Pamela M. Calarese Part ...
Page ix
... risk factors, and the biology of lung cancer. Also, there is a discussion about the controversies in detecting and screening for lung cancer. Part Two presents the various treatment modalities and the issues that surround the procedures ...
... risk factors, and the biology of lung cancer. Also, there is a discussion about the controversies in detecting and screening for lung cancer. Part Two presents the various treatment modalities and the issues that surround the procedures ...
Page 3
... risk factors, disease progression, treatment options, and quality of life for the affected individuals. It is our duty as health professionals to stimulate more interest in researchers and the community at large. As healthcare ...
... risk factors, disease progression, treatment options, and quality of life for the affected individuals. It is our duty as health professionals to stimulate more interest in researchers and the community at large. As healthcare ...
Page 5
... risk of lung cancer goes up with age. The SEER data reports the median age at the time of diagnosis is 71 years of age (Reis, et al., 2007). There was no one under the age of 20 years diagnosed with the disease. The highest group was ...
... risk of lung cancer goes up with age. The SEER data reports the median age at the time of diagnosis is 71 years of age (Reis, et al., 2007). There was no one under the age of 20 years diagnosed with the disease. The highest group was ...
Page 8
... risks of smoking in lung cancer. Studies have shown that 87% of all lung cancers are related to smoking (American Cancer ... risk of lung cancer. Nicotine addiction is discussed further in Chapter 16, Understanding and Treat- ing Tobacco ...
... risks of smoking in lung cancer. Studies have shown that 87% of all lung cancers are related to smoking (American Cancer ... risk of lung cancer. Nicotine addiction is discussed further in Chapter 16, Understanding and Treat- ing Tobacco ...
Contents
Oncology Treatment Modalities | 45 |
Special Issues Facing Individuals with Lung Cancer | 117 |
Psychosocial Issues of Individuals with Lung Cancer | 231 |
Assistance and Resources for Individuals Facing Lung Cancer | 255 |
Media and Future Research Directions | 301 |
Index | 353 |
Other editions - View all
Common terms and phrases
adjuvant agents aprepitant associated bevacizumab breathing breathlessness Bruera carboplatin carcinoma cell lung cancer chemotherapy chronic cisplatin Clinical Oncology clinical trials combination diagnosis disease docetaxel dose drug dyspnea EGFR erlotinib etoposide evaluation evidence-based factors fatigue gefitinib gemcitabine gene improve increased individuals indoor radon Internet intervention irinotecan Journal of Clinical lung cancer patients Medicine ment metastatic months NCCN nicotine non-small cell lung NSCLC Nursing Forum Oncology Nursing Oncology Nursing Forum paclitaxel palliative palliative care patient navigation patients and families patients with lung pemetrexed phase potential pulmonary quit smoking radiation therapy radiotherapy radon randomized receptors regimen reported resection respiratory response rate risk role SCLC score screening Sekido side effects small cell lung smoking cessation stage strategies support group surgical survival rate Symptom Management Table tients tion tobacco topotecan toxicity treat treatment tumor versus vinorelbine weight loss